Research Grants Program

Perhaps nowhere else in dermatology is so little known about a disorder that affects so many. Because the cause of rosacea is unknown and there is no cure, the National Rosacea Society's research grants program was established in 2000 to encourage and support research into the potential causes and other key aspects of this condition that may lead to improvements in its treatment and potential prevention or cure. Since its founding, the research grants program has awarded more than $1.5 million to researchers for a wide range of rosacea-related studies, and the program is funded by donations from many thousands of individuals who wish to improve the lives of those affected by rosacea. Join the fight against rosacea. Donate to this important program today.

To apply for a research grant, click here. Grants are available to researchers worldwide.

Awarded Grants

Grants for 66 studies have been awarded to date, and have led to further investigations in such promising areas as the immune system, nervous systems, facial blood vessels, microbes, Demodex mites and genetics.

Research Results

As studies funded by the National Rosacea Society are completed, reports on results are published on this site and in Rosacea Review.

Medical Advisory Board

Grant applications are reviewed and selected for funding by the Society's medical advisory board, composed of leading experts on rosacea.

Dr. Richard Granstein, Chairman
Chairman of Dermatology
Weill Cornell Medical College

Dr. Frank Powell
Consultant Dermatologist
Regional Centre of Dermatology
Dublin, Ireland
(former EADV president)

Dr. Hilary Baldwin
Associate Professor of Dermatology
SUNY Downstate Medical Center

Dr. Martin Steinhoff
Chairman of Dermatology
Director, Charles Institute of Dermatology
University College, Dublin

Dr. Lynn Drake
Harvard Medical School
(former AAD president)

Honorary Members
Dr. Jonathan Wilkin
Former Director, Dermatologic
and Dental Drug Products
Food and Drug Administration

Dr. Richard Gallo
Chief, Division of Dermatology
University of California - San Diego

Dr. Mark Dahl
Professor Emeritus
The Mayo Clinic College of Medicine
(former AAD president)

Dr. Julie Harper
Clinical Associate Professor of Dermatology
University of Alabama-Birmingham

Dr. Michael Detmar
Professor of Pharmacogenomics
Federal Institute of Technology
Zurich, Switzerland

Dr. Sewon Kang
Chairman of Dermatology
Johns Hopkins University School of Medicine

Dr. Marian Macsai
Professor of Ophthalmology
University of Chicago

Dr. Alexa Boer Kimball
Director, Clinical Unit for
Research Trials in Skin
Harvard Medical School

Dr. Richard Odom
Professor of Clinical Dermatology
University of California - San Francisco
(former AAD president)

Dr. Mark Mannis
Chairman of Ophthalmology
University of California-Davis

Dr. Diane Thiboutot
Professor of Dermatology
Pennsylvania State University

Classification of Rosacea

A standard classification system was developed and published by the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea to unify research, improve clinical diagnosis and provide common terminology for communications. It can be viewed online here.

Grading of Rosacea

A standard grading system for rosacea was published by the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea to unify research and improve clinical assessment. It can be viewed online here.

Contact Us

National Rosacea Society
196 James St.
Barrington, IL 60010

Our Mission

The National Rosacea Society is a 501(c)(3) nonprofit organization whose mission is to improve the lives of people with rosacea by raising awareness, providing public health information and supporting medical research on this widespread but little-known disorder. The information the Society provides should not be considered medical advice, nor is it intended to replace

consultation with a qualified physician. The Society does not evaluate, endorse or recommend any particular medications, products, equipment or treatments. Rosacea may vary substantially from one patient to another, and treatment must be tailored by a physician for each individual case. For more information, visit About Us.